Skip to main content

Healthcare Associated Infection

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Xenex Disinfection Services
1 program
Pulsed xenon ultravioletN/A1 trial
Active Trials
NCT03349268Completed25,732Est. Apr 2020
Ondine Biomedical
Ondine BiomedicalBC - Vancouver
1 program
Methylene Blue OnlyPHASE_1_21 trial
Active Trials
NCT05797818Completed28Est. Feb 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ondine BiomedicalMethylene Blue Only
Xenex Disinfection ServicesPulsed xenon ultraviolet

Clinical Trials (2)

Total enrollment: 25,760 patients across 2 trials

NCT05797818Ondine BiomedicalMethylene Blue Only

Red Light Photobiomodulation and Topical Disinfectants

Start: Jan 2023Est. completion: Feb 202328 patients
Phase 1/2Completed

Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection

Start: Jul 2017Est. completion: Apr 202025,732 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.